全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

A Bronchopulmonary Onset of Candidemia Revealing a Granulomatosis with Polyangiitis

DOI: 10.4236/crcm.2024.135016, PP. 147-154

Keywords: Candidemia, C. glabrata, Pulmonary Candidiasis, Vasculitis, Immunodepression, Granulomatosis with Polyangiitis, Cavitary Lesions, Antifungal Therapy, Immunosuppressants

Full-Text   Cite this paper   Add to My Lib

Abstract:

Candidemia is defined as being a yeast infection confirmed by the presence of at least one positive Candida blood culture. It is a life threatening infection causing high mortality. The clinical signs are generally compatible with the causative agent (whether there is a deep venous catheter or not). On the other hand and according to the 2012 Revised Chapel Hill Classification, granulomatosis with polyangiitis GPA is classified as a vasculitis associated with antineutrophil cytoplasmic antibodies ANCA. It is a systemic disease characterized by the anatomopathological aspect of granuloma. We report the case of a patient who presented an atypical and a very rare revealing mode of GPA which was a bronchopulmonary candidiasis complicated by candidemia. Despite its controversy, the combination in the acute phase of antifungal treatment based on intravenous voriconazole and glucocorticoid therapy has made it possible to control candidemia and calm vasculitis.

References

[1]  Casadevall, A. (2018) Fungal Diseases in the 21st Century: The Near and Far Horizons. Pathogens & Immunity, 3, 183.
https://doi.org/10.20411/pai.v3i2.249
[2]  Develoux, M. and Bretagne, S. (2005) Candidoses et Levuroses Diverses. EMC-Maladies Infectieuses, 2, 119-139.
https://doi.org/10.1016/j.emcmi.2005.04.001
[3]  Ben-Ami, R. (2023) Systemic Antifungal Therapy for Invasive Pulmonary Infections. Journal of Fungi, 9, 144.
https://doi.org/10.3390/jof9020144
[4]  Pfaller, M.A. and Diekema, D.J. (2007) Epidemiology of Invasive Candidiasis: A Persistent Public Health Problem. Clinical Microbiology Reviews, 20, 133-163.
https://doi.org/10.1128/CMR.00029-06
[5]  Haron, E., Vartivarian, S., Anaissie, E., Dekmezian, R. and Bodey, G.P. (1993) Primary Candida pneumonia. Experience at a Large Cancer Center and Review of the Literature. Medicine, 2, 137-142.
https://doi.org/10.1097/00005792-199372030-00001
[6]  Rodriguez-Adrian, L.J., King, R.T., Tamayo-Derat, L.G., Miller, J.W., Garcia, C.A. and Rex, J.H. (2003) Retinal Lesions as Clues to Disseminated Bacterial and Candidal Infections: Frequency, Natural History, and Etiology. Medicine, 82, 187-202.
https://doi.org/10.1097/01.md.0000076008.64510.f1
[7]  Azoulay, É., Limal, N., Mayaud, C. and Schlemmer, B. (2001) Prélèvement pulmonaire positif à Candida: Infection nosocomiale ou colonisation? Réanimation, 10, 323-328.
https://doi.org/10.1016/S1164-6756(01)00120-7
[8]  Rodriguez, C.F., et al. (2017) The Effectiveness of Voriconazole in Therapy of Candida glabrata’s Biofilms Oral Infections and Its Influence on the Matrix Composition and Gene Expression. Mycopathologia, 182, 653-664.
https://doi.org/10.1007/s11046-017-0135-7
[9]  Scott, L.J. and Simpson, D. (2007) Voriconazole: A Review of Its Use in the Management of Invasive Fungal Infections. Drugs, 67, 269-298.
https://doi.org/10.2165/00003495-200767020-00009
[10]  Jeu, L.A., et al. (2003) Voriconazole. Clinical Therapeutics, 25, 1321-1381.
https://doi.org/10.1016/S0149-2918(03)80126-1
[11]  Patterson, T.F., et al. (2016) Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Disease Society of America. Clinical Infectious Diseases, 63, e1-e60.
https://doi.org/10.1093/cid/ciw326
[12]  Moosig, F., Holle, J.U. and Gross, W.L. (2009) Value of Anti-Infective Chemoprophylaxis in Primary Systemic Vasculitis: What Is the Evidence? Arthritis Research & Therapy, 11, 1-11.
https://doi.org/10.1186/ar2826
[13]  Gøtzsche, P.C. and Johansen, H.K. (2002) Nystatin Prophylaxis and Treatment in Severely Immunodepressed Patients. Cochrane Database of Systematic Reviews, CD002033.
https://doi.org/10.1002/14651858.CD002033

Full-Text

Contact Us

[email protected]

QQ:3279437679

WhatsApp +8615387084133